5-alpha Reductase Inhibitors Humans Male Oxidoreductases Prospective Studies *Prostatic Hyperplasia/drug therapy *Prostatic Neoplasms/drug therapy 5?-reductase inhibitors Bph Prostate cancer cancer specific mortality meta-analysis

Adrenergic beta-3 receptor agonists Lower urinary tract symptoms Prostatic hyperplasia Neurourology Journal is the second author of this article. However she played no role whatsoever in the editorial evaluation of this article or the decision to publish it. Except for that no potential conflict of interest relevant to this article was reported.

Humans Hyperthermia Induced Lower Urinary Tract Symptoms/etiology Male Middle Aged Prostatic Hyperplasia/complications/*therapy Radiofrequency Therapy Randomized Controlled Trials as Topic Steam Treatment Outcome

Aged Arteries Ejaculation Embolization Therapeutic Humans Lower Urinary Tract Symptoms/*therapy Male Penile Erection Postoperative Complications/etiology Prostate/*blood supply Prostatic Hyperplasia Quality of Life Randomized Controlled Trials as Topic Retreatment/statistics & numerical data Sexual Dysfunction Physiological/etiology *Transurethral Resection of Prostate Treatment Outcome

Aged Humans Lower Urinary Tract Symptoms/*etiology Male Prostatic Hyperplasia Transurethral Resection of Prostate Urethra/physiopathology

Aged Aged 80 and over Ejaculation Humans Lower Urinary Tract Symptoms/etiology Male Middle Aged Organ Size Penile Erection Prostate/pathology Prostatic Hyperplasia/complications Quality of Life Retreatment/statistics & numerical data Robotic Surgical Procedures Surgery Computer-Assisted/methods Transurethral Resection of Prostate *Water

Humans Lower Urinary Tract Symptoms Male Phosphodiesterase 5 Inhibitors/administration & dosage/adverse effects Placebos Prostatic Hyperplasia/complications/*etiology Quality of Life Regression Analysis Severity of Illness Index Lower urinary tract symptoms Meta-analysis Phosphodiesterase 5 inhibitor Placebo Prostatic hyperplasia

Humans Laser Therapy Male Patient Selection Preoperative Period Prostatic Hyperplasia/complications/physiopathology *Quality of Life Transurethral Resection of Prostate/*adverse effects/methods Treatment Outcome Urinary Bladder Underactive/etiology/*physiopathology *Urodynamics *muscle hypertonia *prostate *prostatic hyperplasia *urethra

5 alpha-reductase inhibitor benign prostatic hyperplasia meta-analysis

Adrenergic alpha-Antagonists Benzilates Drug Combinations Ethamsylate Humans Indoles Lower Urinary Tract Symptoms Male Naphthalenes Piperazines Plant Extracts Prostatic Hyperplasia Prostatism Quality of Life Randomized Controlled Trials as Topic Sulfonamides Tamsulosin Urological Agents

Arteries Embolization Therapeutic/*adverse effects/methods/standards Humans Kallikreins/blood Lower Urinary Tract Symptoms/blood/etiology/*therapy Male Practice Guidelines as Topic Prostate/blood supply Prostate-Specific Antigen/blood Prostatic Hyperplasia/blood/complications/*therapy Quality of Life Treatment Outcome *arteries *embolization *investigational *prostatic hyperplasia *therapeutic *therapies *treatment outcome

Tamsulosin Benign Prostatic Hyperplasia Meta Analysis

Aged Humans Male Middle Aged *Patient Selection Prostate/surgery Prostatic Hyperplasia Quality of Life *Transurethral Resection of Prostate Treatment Outcome Urinary Bladder Neck Obstruction *Urodynamics

Adrenergic alpha-Antagonists/administration & dosage/*therapeutic use Cholinergic Antagonists/administration & dosage Drug Therapy Combination Humans *Lower Urinary Tract Symptoms Male Prostatic Hyperplasia/*diagnosis/*drug therapy Publication Bias Quality of Life Treatment Outcome

Adrenergic alpha-1 Receptor Antagonists Aged Humans Indoles Lower Urinary Tract Symptoms Male Naphthalenes Piperazines Prostatic Hyperplasia Quinazolines Randomized Controlled Trials as Topic Urological Agents

Adrenergic alpha-1 Receptor Antagonists/*administration & dosage Adrenergic alpha-Antagonists Dose-Response Relationship Drug Humans Male Middle Aged Prostatic Hyperplasia *Quality of Life Sulfonamides/*administration & dosage Tamsulosin Prostatic hyperplasia alpha blockers

Botulinum Toxins Type A/administration & dosage Humans Injections Male Neuromuscular Agents/administration & dosage Prostatic Hyperplasia/*drug therapy Treatment Outcome Benign prostatic hyperplasia Botulinum toxin Meta-analysis Placebo

Humans Aged Cystectomy/methods *Urinary Bladder Neoplasms/surgery Urinary Bladder *Urinary Diversion/methods Hospital Mortality Bladder cancer Complications Epidemiology Mortality Radical cystectomy Urinary diversions

androgen suppression therapy bladder cancer incidence meta-analysis recurrence commercial or financial relationships that could be construed as a potential conflict of interest.

Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carcinoma Transitional Cell/*drug therapy/*pathology Female Humans Immune Checkpoint Inhibitors/*therapeutic use Liver Neoplasms/secondary Male Middle Aged Survival Analysis Urinary Bladder Neoplasms/*drug therapy/*pathology bladder cancer immune checkpoint inhibitors immunotherapy meta-analysis urothelial carcinoma